ADIPOQ and obesity disorder: As reported elsewhere, patients with obesity (cohort B, baseline) exhibited lower circulating levels of adiponectin [34] and apoM [30] compared to individuals with overweight (cohort A), consistent with the previously mentioned negative association of plasma adiponectin and apoM with fat mass.